List of Contributors |
|
xiii | |
Series Preface |
|
xix | |
Preface |
|
xxi | |
Part I: Basics of Carbon Nanomaterials |
|
1 | (62) |
|
1 Introduction to Carbon Structures |
|
|
3 | (12) |
|
|
|
|
3 | (1) |
|
|
4 | (1) |
|
|
4 | (2) |
|
|
6 | (4) |
|
|
6 | (2) |
|
|
8 | (2) |
|
|
10 | (2) |
|
|
10 | (1) |
|
|
11 | (1) |
|
1.6 Nanodiamonds and Carbon Dots |
|
|
12 | (1) |
|
|
13 | (1) |
|
|
13 | (2) |
|
2 Using Polymers to Enhance the Carbon Nanomaterial Biointerface |
|
|
15 | (28) |
|
|
|
|
|
|
|
|
15 | (1) |
|
2.2 Colloidal Stability of CNMs |
|
|
16 | (2) |
|
2.3 Functionalization of CNMs with Polymers |
|
|
18 | (1) |
|
2.3.1 Noncovalent Approaches |
|
|
18 | (1) |
|
2.3.2 Covalent Approaches |
|
|
18 | (1) |
|
2.4 Influence of Polymers on the Spectral Properties of CNMs |
|
|
19 | (3) |
|
2.5 Functionalizing CNMs with Antifouling Polymers for Bioapplications |
|
|
22 | (4) |
|
2.6 Functionalization of CNMs with Stimuli-Responsive Polymers |
|
|
26 | (3) |
|
2.6.1 Carbon Nanoparticles with Thermoresponsive Polymers |
|
|
27 | (1) |
|
2.6.2 pH-Responsive Carbon Nanoparticles |
|
|
27 | (1) |
|
2.6.3 Redox-Responsive Carbon Nanoparticles |
|
|
28 | (1) |
|
2.6.4 Multi-Responsive Carbon Nanoparticles |
|
|
28 | (1) |
|
2.7 Functionalization of CNMs with Polymers for Delivery of Nucleic Acids |
|
|
29 | (3) |
|
|
32 | (2) |
|
|
34 | (1) |
|
|
34 | (9) |
|
3 Carbon Nanomaterials for Optical Bioimaging and Phototherapy |
|
|
43 | (20) |
|
|
|
|
43 | (1) |
|
3.2 Surface Functionalization of Carbon Nanomaterials |
|
|
43 | (2) |
|
3.3 Carbon Nanomaterials for Optical Imaging |
|
|
45 | (6) |
|
3.3.1 Intrinsic Fluorescence of Carbon Nanomaterials |
|
|
45 | (1) |
|
3.3.2 Imaging Utilizing Intrinsic Fluorescence Features of Carbon Nanomaterials |
|
|
46 | (5) |
|
3.3.3 Imaging with Fluorescently Labeled Carbon Nanomaterials |
|
|
51 | (1) |
|
3.4 Carbon Nanomaterials for Phototherapies of Cancer |
|
|
51 | (5) |
|
3.4.1 Photothermal Therapy |
|
|
52 | (1) |
|
3.4.2 Photodynamic Therapy |
|
|
53 | (3) |
|
3.5 Conclusions and Outlook |
|
|
56 | (1) |
|
|
56 | (7) |
Part II: Bioimaging and Bioanalysis |
|
63 | (202) |
|
4 High-Resolution and High-Contrast Fluorescence Imaging with Carbon Nanomaterials for Preclinical and Clinical Applications |
|
|
65 | (22) |
|
|
|
|
65 | (1) |
|
4.2 Survey of Carbon Nanomaterials |
|
|
66 | (3) |
|
4.2.1 Fluorescent Nanodiamonds |
|
|
66 | (1) |
|
|
66 | (3) |
|
|
69 | (1) |
|
|
69 | (1) |
|
4.3 Fluorescent Properties of FNDs and SWCNTs |
|
|
69 | (2) |
|
|
69 | (2) |
|
|
71 | (1) |
|
4.4 Survey of High-Resolution and High-Contrast Imaging |
|
|
71 | (7) |
|
4.4.1 General Considerations for Eventual Human Use |
|
|
71 | (1) |
|
4.4.2 General Considerations for Achieving High-Resolution and High-Contrast Imaging |
|
|
72 | (1) |
|
4.4.2.1 Photoacoustic Imaging (PAI) |
|
|
72 | (1) |
|
4.4.2.2 X-ray Computed Tomographic (CT) Imaging |
|
|
73 | (1) |
|
4.4.2.3 Magnetic Resonance Imaging (MRI) |
|
|
73 | (1) |
|
4.4.2.4 Image Alignment and Drift Correction |
|
|
74 | (1) |
|
4.4.3 Preclinical and Clinical Optical Imaging with CNMs |
|
|
74 | (1) |
|
4.4.4 Optical Imaging in the Short-Wavelength Window (approximately 650-950nm) |
|
|
74 | (1) |
|
4.4.4.1 Optical Imaging Beyond the Diffraction Limit |
|
|
75 | (1) |
|
4.4.4.2 Selective Modulation of Emission |
|
|
75 | (1) |
|
4.4.4.3 Time-Gated Fluorescence Lifetime Imaging |
|
|
77 | (1) |
|
4.4.5 Optical Imaging in the Long-Wavelength Window (approximately 950-1400nm) |
|
|
77 | (1) |
|
|
78 | (1) |
|
|
79 | (8) |
|
5 Carbon Nanomaterials for Deep-Tissue Imaging in the NIR Spectral Window |
|
|
87 | (28) |
|
|
|
|
87 | (2) |
|
5.1.1 Transparent Optical Windows in Biological Tissue |
|
|
87 | (1) |
|
5.1.2 Near-Infrared Imaging Materials |
|
|
88 | (1) |
|
5.2 Carbon Nanomaterials for NIR Imaging |
|
|
89 | (16) |
|
5.2.1 Biocompatibility of CNMs |
|
|
90 | (1) |
|
5.2.2 Fluorescence of CNMs Probes |
|
|
91 | (1) |
|
5.2.3 Covalent and Noncovalent Functionalization |
|
|
91 | (1) |
|
5.2.4 CNMs as Bioimaging Platforms |
|
|
91 | (1) |
|
|
91 | (1) |
|
|
93 | (1) |
|
5.2.4.3 Graphene Derivatives |
|
|
99 | (1) |
|
|
100 | (1) |
|
5.2.4.5 Carbon Nano-onions |
|
|
102 | (1) |
|
|
104 | (1) |
|
5.3 Conclusions and Outlook |
|
|
105 | (1) |
|
|
106 | (1) |
|
|
106 | (9) |
|
6 Tracking Photoluminescent Carbon Nanomaterials in Biological Systems |
|
|
115 | (24) |
|
|
|
|
|
115 | (1) |
|
|
115 | (1) |
|
6.2 Tracking Cells in Organisms with Fluorescent Nanodiamonds |
|
|
116 | (4) |
|
6.3 Monitoring Inter and Intra Cellular Dynamics with Fluorescent Nanodiamonds |
|
|
120 | (7) |
|
6.4 Single-Walled Carbon Nanotubes: A Near-Infrared Optical Probe of the Nanoscale Extracellular Space in Live Brain Tissue |
|
|
127 | (4) |
|
|
131 | (1) |
|
|
132 | (7) |
|
7 Photoacoustic Imaging with Carbon Nanomaterials |
|
|
139 | (28) |
|
|
|
|
|
139 | (1) |
|
|
139 | (1) |
|
7.2 Photoacoustic Imaging Systems |
|
|
140 | (5) |
|
7.2.1 Photoacoustic Microscopy |
|
|
141 | (1) |
|
7.2.2 Photoacoustic Computed Tomography |
|
|
142 | (3) |
|
7.3 Photoacoustic Application of Carbon Nanomaterials |
|
|
145 | (16) |
|
7.3.1 Carbon Nanomaterials for Photoacoustic Imaging Contrast Agents |
|
|
146 | (3) |
|
7.3.2 Carbon Nanomaterials for Multimodal Photoacoustic Imaging |
|
|
149 | (7) |
|
7.3.3 Carbon Nanomaterials for Photoacoustic Image-Guided Therapy |
|
|
156 | (4) |
|
7.3.4 Conclusions and Future Perspective |
|
|
160 | (1) |
|
|
161 | (1) |
|
|
162 | (5) |
|
8 Carbon Nanomaterial Sensors for Cancer and Disease Diagnosis |
|
|
167 | (36) |
|
|
|
|
|
|
|
|
167 | (2) |
|
8.2 Detection of VOC by Using Gas/Vapor Sensors for Cancer and Disease Diagnosis |
|
|
169 | (10) |
|
8.2.1 Carbon Nanodots (CNDs) and Graphene Quantum Dots (GQDs) for VOC Sensors |
|
|
171 | (2) |
|
8.2.2 Carbon Nanotubes (CNTs) for VOC Sensors |
|
|
173 | (3) |
|
8.2.3 Graphene for VOC Sensors |
|
|
176 | (3) |
|
8.3 Detection of Biomarkers Using Biosensors for Cancer and Disease Diagnosis |
|
|
179 | (13) |
|
8.3.1 Carbon Nanodot-and Graphene Quantum Dot-Based Biosensors for Disease Biomarkers Detection |
|
|
179 | (3) |
|
8.3.2 Carbon Nanotube-Based Biosensors for Cancer Biomarker Detection |
|
|
182 | (4) |
|
8.3.3 Carbon Nanotube-Based Biosensors for Disease Biomarker Detection |
|
|
186 | (2) |
|
8.3.4 Graphene-Based Biosensors for Cancer Biomarker Detection |
|
|
188 | (2) |
|
8.3.5 Graphene-Based Biosensors for Disease Biomarker Detection |
|
|
190 | (2) |
|
8.4 Conclusions and Perspectives |
|
|
192 | (1) |
|
|
193 | (1) |
|
|
193 | (10) |
|
9 Recent Advances in Carbon Dots for Bioanalysis and the Future Perspectives |
|
|
203 | (62) |
|
|
|
|
|
203 | (2) |
|
|
205 | (11) |
|
9.2.1 Synthesis Approaches |
|
|
205 | (1) |
|
|
206 | (1) |
|
9.2.2.1 Absorbance and Photoluminescence (PL) |
|
|
206 | (1) |
|
9.2.2.2 Quantum Yield (QY) |
|
|
210 | (1) |
|
9.2.2.3 Photoluminescence Origins |
|
|
210 | (1) |
|
9.2.2.4 Up-Conversion Photoluminescence (UCPL) |
|
|
211 | (1) |
|
|
212 | (1) |
|
9.2.3 Physical and Chemical Properties |
|
|
213 | (1) |
|
9.2.4 Biosafety Assessments |
|
|
214 | (2) |
|
9.3 Bioengineering of CDs for Bioanalysis |
|
|
216 | (5) |
|
9.3.1 Functionalization Mechanism and Strategies |
|
|
216 | (1) |
|
9.3.1.1 Chemical Functionalization |
|
|
216 | (1) |
|
|
217 | (1) |
|
9.3.1.3 Coupling with Gold Nanoparticles |
|
|
217 | (1) |
|
9.3.1.4 Fabrication onto Solid Polymeric Matrices |
|
|
218 | (1) |
|
9.3.2 Biomolecules Grafted on CDs as Sensing Receptors |
|
|
218 | (1) |
|
9.3.2.1 Deoxyribonucleic Acid (DNA) |
|
|
218 | (1) |
|
|
219 | (1) |
|
9.3.2.3 Proteins/Peptides |
|
|
219 | (1) |
|
|
220 | (1) |
|
9.4 Bioanalysis Applications of CDs |
|
|
221 | (19) |
|
9.4.1 Biosensing Mechanism/Transduction Schemes |
|
|
221 | (1) |
|
|
222 | (1) |
|
9.4.1.2 Chemiluminescence (CL) |
|
|
223 | (1) |
|
9.4.1.3 Electrochemiluminescence (ECL) |
|
|
224 | (1) |
|
|
224 | (1) |
|
9.4.2 Uses of CDs in Bioanalysis |
|
|
225 | (1) |
|
9.4.2.1 Heavy Metals/Elements |
|
|
225 | (1) |
|
9.4.2.2 Reactive Oxygen/Nitrogen Species (ROS/RNS) |
|
|
226 | (1) |
|
|
227 | (1) |
|
9.4.2.4 Small Molecules/Pharmaceutical Drugs/Natural Compounds |
|
|
228 | (1) |
|
|
230 | (1) |
|
9.4.2.6 Enzyme Activities and Inhibitor Screening |
|
|
231 | (1) |
|
|
232 | (1) |
|
|
234 | (1) |
|
9.4.3 Solid-State Sensing for Point-of-Care Diagnostic Kits |
|
|
234 | (2) |
|
9.4.4 Bioimaging/Real-Time Monitoring |
|
|
236 | (2) |
|
|
238 | (2) |
|
|
240 | (2) |
|
9.5.1 Better Understanding of PL Mechanisms |
|
|
240 | (1) |
|
9.5.2 Establishment of Systematic Synthesis Protocol |
|
|
241 | (1) |
|
9.5.3 QY Improvement and Spectral Expansion to Longer Wavelength |
|
|
241 | (1) |
|
9.5.4 Sensitivity Improvement for Solid-State Sensing |
|
|
242 | (1) |
|
|
242 | (1) |
|
|
242 | (23) |
Part III: Therapy |
|
265 | (76) |
|
10 Functionalized Carbon Nanomaterials for Drug Delivery |
|
|
267 | (22) |
|
|
|
267 | (1) |
|
10.2 Direct Fabrication of Graphene-Based Composite with Photosensitizer for Cancer Phototherapy |
|
|
268 | (6) |
|
10.2.1 Fabrication of Graphene-Based Composite with Chlorin e6 (G-Ce6) |
|
|
268 | (1) |
|
10.2.2 Characterization of G-Ce6 |
|
|
268 | (4) |
|
10.2.3 In vitro Evaluation of G-Ce6 for Cancer Phototherapy |
|
|
272 | (2) |
|
10.3 Polyglycerol-Functionalized Nanodiamond Conjugated with Platinum-Based Drug for Cancer Chemotherapy |
|
|
274 | (6) |
|
10.3.1 Synthesis of Polyglycerol-Functionalized Nanodiamond Conjugated with Platinum-Based Drug and Targeting Peptide |
|
|
274 | (2) |
|
10.3.2 Characterization of Polyglycerol-Functionalized Nanodiamond and the Derivatives |
|
|
276 | (3) |
|
10.3.3 In vitro Evaluation of Polyglycerol-Functionalized Nanodiamond Conjugated with Platinum-Based Drug for Cancer Chemotherapy |
|
|
279 | (1) |
|
10.4 Polyglycerol-Functionalized Nanodiamond Hybridized with DNA for Gene Therapy |
|
|
280 | (3) |
|
10.4.1 Synthesis and Characterization of Polyglycerol-Functionalized Nanodiamond Conjugated with Basic Polypeptides |
|
|
280 | (1) |
|
10.4.2 Characterization of Polyglycerol-Functionalized Nanodiamond Hybridized with Plasmid DNA |
|
|
280 | (3) |
|
10.5 Conclusions and Perspectives |
|
|
283 | (2) |
|
|
285 | (1) |
|
|
285 | (4) |
|
11 Multifunctional Graphene-Based Nanocomposites for Cancer Diagnosis and Therapy |
|
|
289 | (20) |
|
|
|
|
|
|
289 | (2) |
|
11.2 Multifunctional Graphene-Based Composites for the Diagnosis/Therapy of Cancer |
|
|
291 | (9) |
|
11.2.1 Metal-Graphene Nanocomposites |
|
|
292 | (1) |
|
11.2.1.1 Gold-Graphene Composites |
|
|
292 | (1) |
|
11.2.1.2 Magnetic Graphene Nanocomposites |
|
|
294 | (1) |
|
11.2.2 Polymeric Graphene Nanocomposites |
|
|
295 | (4) |
|
11.2.3 Graphene Biomaterials for MR Imaging |
|
|
299 | (1) |
|
11.3 Multimodal Graphene-Based Composites for the Radiotherapy of Cancer |
|
|
300 | (2) |
|
11.4 Graphene-Based Nanobiomaterials for Cancer Diagnosis |
|
|
302 | (1) |
|
|
302 | (1) |
|
|
303 | (1) |
|
|
303 | (6) |
|
12 Carbon Nanomaterials for Photothermal Therapies |
|
|
309 | (32) |
|
|
|
|
|
|
|
|
|
309 | (2) |
|
|
311 | (3) |
|
12.2.1 PTT-Related Physical and Chemical Properties of GO |
|
|
311 | (1) |
|
12.2.2 GO for in vitro PTT |
|
|
312 | (2) |
|
12.2.3 GO for in vivo PTT |
|
|
314 | (1) |
|
12.3 CNTs and CNHs for PTT |
|
|
314 | (4) |
|
12.3.1 Physical and Chemical Properties of CNTs and CNHs Related to PTT |
|
|
315 | (1) |
|
12.3.2 CNTs and CNHs for in vitro PTT |
|
|
316 | (1) |
|
12.3.3 CNTs and CNHs for in vivo PTT |
|
|
316 | (2) |
|
|
318 | (2) |
|
12.4.1 Physical and Chemical Properties of CDs and GDs Related to PTT |
|
|
318 | (1) |
|
12.4.2 CDs and GDs for in vitro PTT |
|
|
319 | (1) |
|
12.4.3 CDs and GDs for in vivo PTT |
|
|
319 | (1) |
|
|
320 | (1) |
|
12.5.1 Physical and Chemical Properties of Fullerenes Related to PTT |
|
|
320 | (1) |
|
12.5.2 Fullerenes for in vitro PTT |
|
|
320 | (1) |
|
12.5.3 Fullerenes for in vivo PTT |
|
|
321 | (1) |
|
12.6 Carbon Nanomaterial-Based Nanocomposites for PTT |
|
|
321 | (3) |
|
12.6.1 GO-Based Nanocomposites for PTT |
|
|
322 | (1) |
|
12.6.2 CNT-Based Nanocomposites for PTT |
|
|
323 | (1) |
|
12.6.3 CD-and GD-Based Nanocomposites for PTT |
|
|
323 | (1) |
|
12.7 Carbon Nanomaterial-Based Combined Therapy with PTT |
|
|
324 | (5) |
|
|
324 | (1) |
|
|
324 | (1) |
|
12.7.3 Photodynamic Therapy (PDT) |
|
|
325 | (1) |
|
|
325 | (2) |
|
|
327 | (1) |
|
12.7.6 Theranostic Applications |
|
|
328 | (1) |
|
12.8 Conclusions and Perspectives |
|
|
329 | (1) |
|
|
330 | (11) |
Index |
|
341 | |